When disease control is the goal, CT doublet plus anti-EGFR is recommended as the 1L treatment for RAS/BRAF WT left-sided tumor, and CT doublet plus anti-VEGF is recommended for RAS/BRAF WT right-sided tumor. Here, EGFR is linked to neoplasm.